Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial

被引：0
|
作者：
Charlotte C. van Ruiten
Mark M. Smits
Megan D. Kok
Erik H. Serné
Daniël H. van Raalte
Mark H. H. Kramer
Max Nieuwdorp
Richard G. IJzerman
机构：
[1] Diabetes Center,Department of Internal Medicine
[2] Amsterdam University Medical Center,Department of Vascular Medicine
[3] Location VU University Medical Center,Department of Vascular Medicine
[4] Amsterdam University Medical Center,Department of Internal Medicine
[5] Location VU University Medical Center,undefined
[6] Amsterdam University Medical Center,undefined
[7] Location AMC,undefined
[8] Amsterdam Diabetes Center,undefined
[9] Amsterdam University Medical Centers (Amsterdam UMC),undefined
[10] Location VU University Medical Center (VUMC),undefined
来源：
Cardiovascular Diabetology | / 21卷
关键词：
SGLT2 inhibitor; Dapagliflozin; GLP-1 receptor agonist; Exenatide; Type 2 diabetes; Blood pressure; Autonomic balance; Hemodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis
    Glasziou, Paul P.
    Clarke, Philip
    Alexander, Jan
    Rajmokan, Mohana
    Beller, Elaine
    Woodward, Mark
    Chalmers, John
    Poulter, Neil
    Patel, Anushka
    MEDICAL JOURNAL OF AUSTRALIA, 2010, 193 (06) : 320 - 324
  • [32] Effect of Exercise on Blood Pressure in Type 2 Diabetes: A Randomized Controlled Trial
    Dobrosielski, Devon A.
    Gibbs, Bethany Barone
    Ouyang, Pamela
    Bonekamp, Susanne
    Clark, Jeanne M.
    Wang, Nae-Yuh
    Silber, Harry A.
    Shapiro, Edward P.
    Stewart, Kerry J.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 (11) : 1453 - 1459
  • [33] Effect of Exercise on Blood Pressure in Type 2 Diabetes: A Randomized Controlled Trial
    Devon A. Dobrosielski
    Bethany Barone Gibbs
    Pamela Ouyang
    Susanne Bonekamp
    Jeanne M. Clark
    Nae-Yuh Wang
    Harry A. Silber
    Edward P. Shapiro
    Kerry J. Stewart
    Journal of General Internal Medicine, 2012, 27 : 1453 - 1459
  • [34] Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial
    Johansen, Mette Y.
    Karstoft, Kristian
    MacDonald, Christopher S.
    Hansen, Katrine B.
    Ellingsgaard, Helga
    Hartmann, Bolette
    Albrechtsen, Nicolai J. Wewer
    Vaag, Allan A.
    Holst, Jens J.
    Pedersen, Bente K.
    Ried-Larsen, Mathias
    DIABETOLOGIA, 2020, 63 (11) : 2410 - 2422
  • [35] Effects of an intensive lifestyle intervention on the underlying mechanisms of improved glycaemic control in individuals with type 2 diabetes: a secondary analysis of a randomised clinical trial
    Mette Y. Johansen
    Kristian Karstoft
    Christopher S. MacDonald
    Katrine B. Hansen
    Helga Ellingsgaard
    Bolette Hartmann
    Nicolai J. Wewer Albrechtsen
    Allan A. Vaag
    Jens J. Holst
    Bente K. Pedersen
    Mathias Ried-Larsen
    Diabetologia, 2020, 63 : 2410 - 2422
  • [36] Effects Of Exercise On Compensatory Mechanisms In People With Type 2 Diabetes: 1-year Randomized Controlled Trial
    Correia, Ines R.
    Hetherington-Rauth, Megan
    Magalhaes, Joao P.
    Rosa, Gil B.
    Sardinha, Luis B.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2021, 53 (08): : 264 - 264
  • [37] Exploring Kidney Oxygenation Responses to Dapagliflozin, Exenatide, and Their Combination in Patients With Type 2 Diabetes and Chronic Kidney Disease: Observations From a Prespecified Pilot Study of a Randomized Crossover Trial
    Apperloo, Ellen M.
    Heerspink, Hiddo J. L.
    van der Aart, Annemarie B.
    Rouw, Dennis
    van Raalte, Daniel H.
    Hoogenberg, Klaas
    Jongs, Niels
    Muskiet, Marcel H. A.
    DIABETES CARE, 2025, 48 (03) : e22 - e24
  • [38] HYPERTENSION Impact of blood pressure lowering in type 2 diabetes
    Glassock, Richard J.
    Bakris, George L.
    NATURE REVIEWS NEPHROLOGY, 2015, 11 (06) : 320 - U21
  • [39] Lowering Blood Pressure in Patients with Type-2-Diabetes
    Pavlicek, V.
    DIABETOLOGE, 2015, 11 (03): : 224 - 225
  • [40] Effects of dapagliflozin and gliclazide on the cardiorenal axis in people with type 2 diabetes
    van Bommel, Erik J. M.
    Smits, Mark M.
    Ruiter, Danique
    Muskiet, Marcel H. A.
    Kramer, Mark H. H.
    Nieuwdorp, Max
    Touw, Daan J.
    Heerspink, Hiddo J. L.
    Joles, Jaap A.
    van Raalte, Daniel H.
    JOURNAL OF HYPERTENSION, 2020, 38 (09) : 1811 - 1819
12345